Fig. 1 · Structure
Documents & Downloads
Elarofiban diTFA
Fibrinogen Receptor Antagonist
Elarofiban diTFA is a potent fibrinogen receptor αIIbβ3 (GPIIb/IIIa) antagonist, existing in its salt form with two trifluoroacetic acid (TFA) molecules. This non-peptide compound exhibits highly effective inhibition with an IC50 of 0.15 nM. Elarofiban diTFA is utilized in research related to platelet-mediated thrombotic disorders, offering significant insights into therapeutic strategies for managing blood clotting conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 198958-89-3 |
| Applications | Fibrinogen Receptor Antagonist |
| Formula | C26H34F6N4O8 |
| Molecular Weight | 644.56 |
| SMILES | O=C(N[C@H](C1=CN=CC=C1)CC(O)=O)[C@H]2CN(CCC2)C(CCC3CCNCC3)=O.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.